关节腔内缓释秋水仙碱在大鼠炎症性关节炎模型中有效
本研究在大鼠角叉菜胶诱导的急性炎症性关节炎模型中,评估关节腔内注射缓释秋水仙碱微球(SR-COL)及缓释秋水仙碱与罗哌卡因组合(PKM-01)的疗效。结果显示SR-COL在减轻疼痛、炎症和关节破坏方面有效,PKM-01提供强而快速的镇痛并具抗炎作用,踝关节注射后血秋水仙碱水平显著低于毒性阈值。作者认为PKM-01可能成为急性炎症性关节炎的有效安全治疗选择,并计划在痛风发作患者中开展临床试验。
要点
- SR-COL在疼痛、炎症和关节破坏所有参数上均显示疗效。
- PKM-01提供强而快速的镇痛作用并具抗炎特性。
- 踝关节注射后血秋水仙碱水平显著低于毒性阈值。
核心结论
- 这些数据表明PKM-01可能作为急性炎症性关节炎的有效且安全的治疗选择。
- 计划在痛风发作患者中开展临床试验。
研究设计与样本
- 本研究采用关节腔内角叉菜胶诱导的膝或踝关节炎大鼠模型。
- PKM-01将罗哌卡因与缓释秋水仙碱组合,使用聚乳酸-羟基乙酸共聚物基质聚合物制备。
- 治疗(磷酸盐缓冲盐水、地塞米松、SR-COL、罗哌卡因或PKM-01)在角叉菜胶注射后立即经关节腔内给药。
主要发现
- 所有动物在角叉菜胶注射后均出现急性疼痛性和破坏性关节炎。
- 罗哌卡因有效缓解疼痛,但对炎症或关节破坏无显著影响。
- SR-COL在所有参数上均显示减轻疼痛、炎症和关节破坏的疗效。
- PKM-01提供强而快速的镇痛效果并表现出抗炎特性,关节炎症和破坏的组织学分析证实了这一点。
- 踝关节注射后血秋水仙碱水平显著低于毒性阈值。
临床怎么用
- 作者认为PKM-01可能作为急性炎症性关节炎的有效且安全的治疗选择。
- 作者计划在痛风发作患者中开展临床试验。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Gout is a common disease causing excruciatingly painful and disabling flares. Although currently approved treatments for gout flares are generally effective, their use is restricted in many patients who present contraindications. There is a clear unmet need for treatments, with a rapid onset of action and a good safety profile. This study evaluates the efficacy of intra-articular (IA) colchicine (COL)-loaded microspheres enabling sustained-release colchicine (SR-COL), and of a combination of SR-COL with an anaesthetic (Ropivacaine HCl, ROPI) (PKM-01) in a rat model of acute inflammatory arthritis. METHODS: PKM-01 combines ROPI with SR-COL, prepared using a polylactic-co-glycolic acid matrix polymer. A model of IA carrageenan (CAR)-induced arthritis in knees or ankles was adapted for this study. Treatments (phosphate buffer saline, dexamethasone, SR-COL, ROPI or PKM-01) were administered intra-articularly immediately following the CAR injection. Pain was assessed using Von Frey filaments or weight-bearing tests. Histological scores assessed joint inflammation and destruction. RESULTS: All animals experienced acute painful and destructive arthritis following CAR injection. ROPI effectively alleviated pain but had no significant impact on inflammation or joint destruction. SR-COL demonstrated efficacy in reducing pain, inflammation and joint destruction across all parameters. PKM-01 provided a strong and rapid analgesic effect and exhibited anti-inflammatory properties, as evidenced by histological analysis of joint inflammation and destruction. Blood levels of COL after ankle injections were significantly below toxicity thresholds. CONCLUSIONS: These data indicate that PKM-01 may serve as an effective and safe treatment option for acute inflammatory arthritis. A clinical trial is planned in gout flare patients.
引用
- Grassot J, Marzouki F, Hervé R, et al. Intra-articular sustained-release colchicine is efficacious in an inflammatory arthritis rat model. RMD Open. 2025. PMID: 41022524. doi:10.1136/rmdopen-2025-005988
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。